Daniel Skovronsky Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 17 hours ago
Daniel Skovronsky has an estimated net worth of at least $93.8 million*, as of Aug. 13, 2025. They own 137,660 shares of LLY stock. They have sold 5,000 shares of LLY stock since 2021, for an estimated $3.7 million.
Daniel Skovronsky $LLY SEC Form 4 Insider Trading
Daniel Skovronsky has filed a total of 4 insider trades in $LLY since 2021. Their most recent trade was a purchase of 1,000 shares, made on Aug 12, 2025. Their largest trade was a sale of 3,950 shares, made on Feb 10, 2025. We estimate that they now own 137,660 shares of $LLY, worth an estimated $90.1 million.
Insider Trading at $LLY
There have been a total of 697 insider trades reported at $LLY since 2021, with 7,845 shares purchased and 13.4 million shares sold. The most active insider traders in $LLY stock have been Donald A Zakrowski, Daniel Skovronsky, and Alonzo Weems. The most recent trade was a purchase of 715 shares reported by Lucas Montarce (EVP & CFO), made on Aug 15, 2025.
History of Insider Stock Trades by Daniel Skovronsky
$LLY Executives and Stock Owners with Insider Trades
-
Donald A Zakrowski, SVP, Finance, & CAO
-
Daniel Skovronsky, EVP, CSO & Pres. LRL & LLY Imm
-
Alonzo Weems, EVP, ERM & CECO
-
Donald A Zakrowski, Chief Accounting Officer
-
Johna Norton, EVP, Global Quality
-
Anne E. White, EVP & Pres, Lilly Neuroscience
-
Ilya Yuffa, SVP & President, LLY Int'l
-
Patrik Jonsson, SVP&Pres, LLY Imm, LLY USA&CCO
-
Alonzo Weems, SVP, ERM & CECO
-
David A Ricks, President, Chair, and CEO
-
Ilya Yuffa, EVP & President, LLY Int'l
-
Ilya Yuffa, EVP&Pres, LLY USA&Global Capab
-
Lucas Montarce, EVP & CFO
-
Naarden Jacob Van, EVP & Pres., Lilly Oncology
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.